UsAgainstAlzehimer's: Power of Us
Get to know UsAgainstAlzheimer’s, what we’ve accomplished, and where we’re headed through our powerful video introduction.
Alzheimer's Patients and Caregivers Celebrate FDA Approval of Lecanemab
CMS and Lecanemab’s manufacturers must work together to provide access to patients.
Congress Delivers Major Wins for Alzheimer’s Patients
Alzheimer’s patients, caregivers, and advocates secured major wins in the end-of-year budget package passed by Congress today. In addition to a $226 million increase in research funding, the bill includes key priorities advocated for by UsAgainstAlzheimer’s.
Lecanemab Trial Data Gives Hope to Alzheimer’s Community
Promising new data released today indicate that help could soon be on the way for people living in the early stages of Alzheimer’s.
The Brain Health Academy
Free, evidence-based courses to equip healthcare and wellness providers with the knowledge and resources to help people reduce the risk of dementia and Alzheimer’s.
Say Hello to BrainGuide
Our platform BrainGuide™ empowers people of all ages and communities to understand and take action on brain health and Alzheimer's disease.
UsAgainstAlzehimer's: Power of Us
Alzheimer's Patients and Caregivers Celebrate FDA Approval of Lecanemab
Congress Delivers Major Wins for Alzheimer’s Patients
Lecanemab Trial Data Gives Hope to Alzheimer’s Community
The Brain Health Academy
Say Hello to BrainGuide

UsAgainstAlzheimer's: Working to End Alzheimer's Disease
The Alzheimer’s pandemic is one of the most significant health and social economic crises of this generation. It is a national and global emergency that has a devastating health, social and economic toll on millions of people living with this disease, their families and caregivers.
UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. Since our founding in 2010, we have taken on the toughest problems in the fight to end Alzheimer’s. Our work is driven by the urgency to find effective treatments and the prevention steps needed to reach the time where no one is lost to Alzheimer’s.
We bring all of “Us” together to:
- Improve brain health and promote earlier detection, diagnosis and intervention
- Champion health equity and access for communities of color and women who are disproportionately impacted by the disease
- Advocate for increased research spending that will speed treatments to market
- Drive changes that matter most to people living with the disease and caregivers
In the past decade, progress has been made, with more hope on the horizon now than ever before.
But every day of delay is another day lost to the millions of people affected by this devastating disease. If nothing changes, by 2050, 14 million Americans will be living with Alzheimer’s at an annual cost of more than $1 trillion. The time to act is now.